Get the Stockscreener App
78.29
1.74%
-1.39
After Hours:
78.31
0.02
+0.03%
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $78.29, with a volume of 1.31M.
It is down -1.74% in the last 24 hours and down -9.00% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$79.68
Open:
$78.89
24h Volume:
1.31M
Relative Volume:
0.70
Market Cap:
$38.49B
Revenue:
$10.03B
Net Income/Loss:
$1.07B
P/E Ratio:
36.08
EPS:
2.17
Net Cash Flow:
$1.39B
1W Performance:
-2.35%
1M Performance:
-9.00%
6M Performance:
-11.82%
1Y Performance:
-22.30%
1-Day Range:
$78.28
$79.04
1-Week Range:
$77.44
$80.06
52-Week Range:
$77.44
$100.71
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
78.29 | 38.49B | 10.03B | 1.07B | 1.39B | 2.17 |
|
ISRG
Intuitive Surgical Inc
|
449.68 | 161.31B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
186.84 | 54.01B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
270.14 | 39.60B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
253.50 | 18.35B | 2.96B | 487.70M | 344.00M | 6.68 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-21-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
Exclusive: Shareholder revolt threatens Alcon's takeover of STAAR Surgical - Investing.com
Exclusive: Shareholder revolt threatens Alcon’s takeover of STAAR Surgical - Investing.com India
New company OpZira formed following Alcon’s acquisition of LumiThera - Ophthalmology Times
Alcon AG stock hits 52-week low at 77.71 USD By Investing.com - Investing.com Nigeria
Alcon announces launch of wavelight plus, fully personalized LASIK treatment, in US and Canada - Ophthalmology Times
STAA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of STAAR Surgical Company is Fair to Shareholders - GlobeNewswire Inc.
Hyperopia Market Overview: Epidemiology, Emerging Therapies, and Key Players | Featuring Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Compa - Barchart.com
Alcon AG stock hits 52-week low at 77.71 USD - Investing.com
Alcon launches first fully personalized LASIK treatment - Eyes On Eyecare
Alcon completes acquisition of LumiThera - Modern Retina
Swing Trade: Will Alcon Inc. benefit from rate cutsWeekly Gains Report & Real-Time Stock Price Movement Reports - Lancaster City Council
Does Alcon Inc. offer margin of safetyCPI Data & Technical Entry and Exit Alerts - Lancaster City Council
Alcon announces first fully personalized LASIK treatment with wavelight plus in the US and Canada - Eyes On Eyecare
North America Intraocular Lens Market Forecast and Company - GlobeNewswire
North America Intraocular Lens Market Forecast and Company Analysis Report 2025-2033 Featuring Alcon, Bausch, Hoya, Johnson & Johnson, STAAR Surgical, Carl Zeiss, Meditec, Novartis, and USIOL - Yahoo Finance
Eye Care’s Digital Revolution: Alcon’s ESCRS 2025 Launches Signal the Future of a $90B Market - MarketsandMarkets
Dana Lynn Alcon Obituary (2025)Price, UTMitchell Funeral Home, Inc.Price - Legacy.com
Short Term Trend Reversal in Alcon Inc. PossibleJuly 2025 Analyst Calls & Community Shared Stock Ideas - beatles.ru
Candlestick Reversal Detected on Alcon Inc.’s ChartTrade Signal Summary & High Conviction Buy Zone Picks - beatles.ru
Alcon Inc. Volume Confirms Breakout — Analysts Bullish2025 Bull vs Bear & Smart Swing Trading Alerts - beatles.ru
Alcon Inc. Moves Into Bullish Territory Based on MACDJuly 2025 PreEarnings & Verified Momentum Watchlists - beatles.ru
Is Alcon Inc. Forming a Bottom PatternJuly 2025 Technicals & Free Accurate Trade Setup Notifications - beatles.ru
Alcon Launches Innovations and Highlights New Study Findings At ESCRS 2025 - MarketScreener
Alcon Inc. Recovery Potential Based on Technical ToolsAnalyst Downgrade & Real-Time Chart Pattern Alerts - beatles.ru
Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025 - Yahoo Finance
Alcon up 4% as FDA approves Tryptyr drops for dry eye - MSN
Alcon downgraded at J.P. Morgan on Q2 results - MSN
Heatmap analysis for Alcon Inc. and competitorsQuarterly Earnings Summary & Verified Swing Trading Watchlist - Newser
Fundamentals Check: Is Alcon Inc. stock technically oversoldJuly 2025 Snapshot & Weekly High Return Opportunities - خودرو بانک
STAAR Surgical's largest holder to vote against Alcon bid - MSN
Is Alcon Inc. a play on infrastructure spending2025 Trading Volume Trends & AI Driven Price Forecasts - خودرو بانک
What is Alcon Inc.’s book value per shareJuly 2025 PostEarnings & Target Return Focused Picks - خودرو بانک
Alcon officially purchases LumiThera - Eyes On Eyecare
Forecasting Alcon Inc. price range with options dataShare Buyback & Verified Trade Idea Suggestions - Newser
With 64% ownership of the shares, Alcon Inc. (VTX:ALC) is heavily dominated by institutional owners - simplywall.st
Alcon Completes Acquisition of LumiThera, Expands Footprint Into Retina Clinic and Dry AMD Space - VisionMonday.com
Technical analysis overview for Alcon Inc. stock2025 Market WrapUp & Community Trade Idea Sharing - Newser
Can Alcon Inc. hit a new high this monthJuly 2025 Short Interest & High Conviction Trade Alerts - Newser
Will earnings trigger a reversal in Alcon Inc.Weekly Earnings Recap & Verified Short-Term Plans - Newser
Alcon and GRAIL: Unlocking Innovation and Efficiency through Strategic Partnerships - Veeva
STAAR Surgical’s largest shareholder opposes Alcon takeover - MSN
Opzira launches with former Lumithera diagnostics - BioWorld MedTech
Creation of OpZira Inc. announced following Alcon's acquisition of LumiThera - Ophthalmology Times
Alcon Stock Rated Buy by BTIG Following TRYPTYR Approval - MSN
Detecting support and resistance levels for Alcon Inc.IPO Watch & Short-Term Swing Trade Alerts - Newser
Alcon Inc. stock trendline breakdownJuly 2025 Closing Moves & High Return Stock Watch Alerts - Newser
Why Alcon Inc. is moving todayJuly 2025 Momentum & Free Expert Approved Momentum Trade Ideas - Newser
Is Alcon Inc. trending in predictive chart modelsMarket Weekly Review & Daily Stock Trend Watchlist - Newser
What momentum shifts mean for Alcon Inc.July 2025 Decliners & Community Consensus Picks - Newser
Real time scanner hits for Alcon Inc. explainedJuly 2025 Reactions & Short-Term High Return Strategies - Newser
Will Alcon Inc. outperform the market2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - Newser
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):